+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver Cancer Drugs Market Research Reports

From
From
From
From
Advanced liver cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced liver cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
Hepatic Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatic Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
From
Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 200 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 230 Pages
  • Global
From
Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Mucinous cystic neoplasm - Pipeline Insight, 2024 - Product Thumbnail Image

Mucinous cystic neoplasm - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
OPDIVO Market Size, Forecast, and Emerging Insight - 2032 - Product Thumbnail Image

OPDIVO Market Size, Forecast, and Emerging Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Cholangiocarcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cholangiocarcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Bile Duct Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Bile Duct Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Biliary Tract Cancer (BTC) - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tract Cancer (BTC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Liver Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Liver Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Hepcidin Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Hepcidin Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Gemcitabine Hydrochloride Market 2024-2028 - Product Thumbnail Image

Gemcitabine Hydrochloride Market 2024-2028

  • Report
  • July 2024
  • 132 Pages
  • Global
From
Doxorubicin Market 2024-2028 - Product Thumbnail Image

Doxorubicin Market 2024-2028

  • Report
  • August 2024
  • 163 Pages
  • Global
From
Liposomal Doxorubicin Market Report and Forecast 2024-2032 - Product Thumbnail Image

Liposomal Doxorubicin Market Report and Forecast 2024-2032

  • Report
  • September 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Liver Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat liver cancer. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy is a type of drug that works by killing cancer cells. Targeted therapy is a type of drug that works by targeting specific molecules in cancer cells. Immunotherapy is a type of drug that works by stimulating the body's own immune system to fight cancer. The Liver Cancer Drugs market is highly competitive, with many companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly developing new drugs and treatments to improve the quality of life for those affected by liver cancer. Show Less Read more